EasySep™ Release 小鼠APC正选试剂盒

使用磁珠解离技术的免疫磁珠正选试剂盒

产品号 #100-0033

通过免疫磁珠正选,分选出APC偶联抗体标记但无磁珠标记的小鼠细胞

产品优势

  • 在40分钟内从小鼠组织中分离出用APC偶联抗体标记的高纯度细胞
  • 无需清洗去除EasySep™ Releasable RapidSpheres™可解离磁珠

产品组分包括

  • EasySep™ Release 小鼠APC正选试剂盒(产品号 #100-0033)
    • EasySep™ Release APC正选抗体混合物,1 mL
    • EasySep™ Releasable RapidSpheres™,1 mL
    • EasySep™Release 缓冲液(浓缩),3 x 1 mL
    • 用于正选的抗小鼠FcR阻断剂,0.5 mL

概述

EasySep™ Release 小鼠 APC 正选试剂盒旨在通过免疫磁珠正选,从小鼠组织中分离出标记APC偶联抗体的细胞。

目的细胞用抗体和磁珠标记,并通过 EasySep™ 磁极进行无柱分选。非目的细胞通过简单倾倒弃去,而目的细胞则保留在试管中。随后,结合在使用EasySep™分离的APC偶联抗体标记的细胞上的磁珠被解离,这些细胞可立即用于下游应用。使用该EasySep™ Release 试剂盒分选之后,细胞表面仍结合有抗体复合物,并可能与Brilliant Violet™偶联的抗体、聚乙二醇修饰的蛋白质或其他化学相关配体相互作用。

 

Magnet Compatibility
• EasySep™ Magnet (Catalog #18000)
• “The Big Easy” EasySep™ Magnet (Catalog #18001)
• EasyEights™ EasySep™ Magnet (Catalog #18103)
• EasyPlate™ EasySep™ Magnet (Catalog #18102)
 
Subtype
Cell Isolation Kits
 
Cell Type
Other
 
Species
Mouse
 
Sample Source
Bone Marrow, Other, Spleen
 
Selection Method
Positive
 
Application
Cell Isolation
 
Brand
EasySep
 
Area of Interest
Immunology

实验数据

Using the EasySep™ Release Mouse APC Positive Selection Kit, the frequencies of CD45+ cells in the starting and isolated fractions are 64.8% and 98.5%, respectively.

Figure 1. Purity of CD45+ Cells Following Cell Isolation with the EasySep™ Release Mouse APC Positive Selection Kit

In the above example, the frequencies of CD45+ cells in the starting and isolated fractions are 64.8% and 98.5%, respectively.

产品说明书及文档

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
100-0033
Lot #
1000157896 or lower
Language
English
Catalog #
100-0033
Lot #
1000157897 or higher
Language
English
Document Type
Safety Data Sheet 1
Catalog #
100-0033
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
100-0033
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Catalog #
100-0033
Lot #
All
Language
English
Document Type
Safety Data Sheet 4
Catalog #
100-0033
Lot #
All
Language
English
Document Type
Safety Data Sheet 5
Catalog #
100-0033
Lot #
All
Language
English

相关材料与文献

Educational Materials (4)

Publications (1)

Short palate, lung, and nasal epithelial clone 1 (SPLUNC1) level determines steroid-resistant airway inflammation in aging. A. K. Jaiswal et al. American journal of physiology. Lung cellular and molecular physiology 2022 jan

Abstract

Asthma and its heterogeneity change with age. Increased airspace neutrophil numbers contribute to severe steroid-resistant asthma exacerbation in the elderly, which correlates with the changes seen in adults with asthma. However, whether that resembles the same disease mechanism and pathophysiology in aged and adults is poorly understood. Here, we sought to address the underlying molecular mechanism of steroid-resistant airway inflammation development and response to corticosteroid (Dex) therapy in aged mice. To study the changes in inflammatory mechanism, we used a clinically relevant treatment model of house-dust mite (HDM)-induced allergic asthma and investigated lung adaptive immune response in adult (20-22 wk old) and aged (80-82 wk old) mice. Our result indicates an age-dependent increase in airway hyperresponsiveness (AHR), mixed granulomatous airway inflammation comprising eosinophils and neutrophils, and Th1/Th17 immune response with progressive decrease in frequencies and numbers of HDM-bearing dendritic cells (DC) accumulation in the draining lymph node (DLn) of aged mice as compared with adult mice. RNA-Seq experiments of the aged lung revealed short palate, lung, and nasal epithelial clone 1 (SPLUNC1) as one of the steroid-responsive genes, which progressively declined with age and further by HDM-induced inflammation. Moreover, we found increased glycolytic reprogramming, maturation/activation of DCs, the proliferation of OT-II cells, and Th2 cytokine secretion with recombinant SPLUNC1 (rSPLUNC1) treatment. Our results indicate a novel immunomodulatory role of SPLUNC1 regulating metabolic adaptation/maturation of DC. An age-dependent decline in the SPLUNC1 level may be involved in developing steroid-resistant airway inflammation and asthma heterogeneity.
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.
版权 © 2025 STEMCELL Technologies 技术有限公司。保留所有权利。